 |
How to Manage Refractory Gastroesophageal Reflux Disease CME DisclosuresRelease Date: November 26, 2007; Valid for credit through November 26, 2008 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| Gastroesophageal reflux disease (GERD) patients who are unresponsive to 4-8 weeks of treatment with proton pump inhibitors (PPIs) twice daily may have refractory GERD, and endoscopy is an appropriate first step. Subsequent differential diagnosis and management depend on the results of endoscopy and other tests, such as pH testing, manometry, and impedance monitoring. - How to Manage Refractory Gastroesophageal Reflux Disease
Joel E. Richter, MD
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2007 Medscape. |
|
|
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
